2023
|
Invention
|
Substituted n-acetyl-l-cysteine derivatives and related compounds.
Novel substituted N-acetyl-L-... |
2019
|
Invention
|
Substituted n-acetyl-l-cysteine derivatives and related compounds. Novel substituted N-acetyl-L-c... |
2016
|
Invention
|
Cysteine prodrugs.
Novel cysteine prodrugs and their use in the treatment of diseases and/or con... |
2014
|
Invention
|
Propionic acids, propionic acid esters, and related compounds. The invention relates to compounds... |
|
Invention
|
Ethyl (2r)-2-acetamido-3-(4-methylbenzoylsulfanyl)propanoate and uses thereof. A novel substitute... |
|
Invention
|
Use of compounds elevating glutathione levels for the treatment of autism, autistic spectrum diso... |
|
G/S
|
Pharmaceutical research and development |
|
Invention
|
S-t-butyl protected cysteine di-peptide analogs and related compounds.
S-t-butyl protected cyste... |
2013
|
Invention
|
Use of compounds elevating glutathione levels for the treatment of parkinson's disease.
Methods ... |
|
Invention
|
The use of compounds elevating glutathione levels for the treatment of parkinson's disease. Metho... |
2012
|
Invention
|
Cysteine prodrugs. Novel cysteine prodrugs and their use in the treatment of diseases and/or cond... |
2011
|
Invention
|
S-t-butyl protected cysteine di-peptide analogs and related compounds. S-t-butyl protected cystei... |
|
Invention
|
S-protected cysteine analogs and related compounds. S-protected cysteine analogs and related comp... |
|
Invention
|
S-protected cysteine analogs and related compounds.
S-protected cysteine analogs and related com... |
|
Invention
|
Improved cysteine-based prodrugs useful in the treatment of schizophrenia. Disclosed are compound... |
|
Invention
|
Propionic acids, propionic acid esters, and related compounds. The invention relates to propionic... |